USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Healthcare Market Research Reports
The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.
Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....
Key Topics Covered in Healthcare:
Drug Development & Innovation:
- Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
- Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
- Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
- Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.
Digital Health & Telehealth:
- Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
- Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
- Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
- Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
- Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.
Medical Devices & Diagnostics:
- Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
- Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
- Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
- Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
- Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
- Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
- Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
- Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
- Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
- Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
- Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.
Other Healthcare Growth Areas:
- Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
- Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.
Clinical Trials & Drug Development Services:
- Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
- Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.
Biopharmaceutical Products:
- Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
- Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.
For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.
-
28 Nov 2023 | Global | Technology Research
Growth Opportunities in Obesity Drugs and Delivery Platforms
GLP-1-based Drugs, Along With Injector and Nanomaterial Delivery Platforms, Drive Transformational Industry Growth
The increasing disposable incomes in developing countries have contributed to a sedentary lifestyle worldwide. The advent of food delivery apps has also increased accessibility to various culinary delights. These factors have contributed mainly to obesity and other lifestyle diseases. People with a body mass index (BMI) of more than or equal to...
$4,950.00 -
21 Dec 2022 | Global | Technology Research
Antibody-drug Conjugates: Technology Growth Opportunities
Disruptive Technologies and a Conducive Funding Environment are Fostering Growth
Antibody-drug conjugates (ADCs) are therapies that target cancer cells with antigen-specific antibodies and highly toxic payloads. ADCs are currently generating interest among drug developers, contract manufacturing companies, regulatory agencies, and other stakeholders. The rise in the number of drug approvals has also sparked interest in further ...
$4,950.00
Special Price $4,207.50 save 15 %
-
20 Dec 2022 | Global | Technology Research
Advances and Growth Opportunities in RNA Vaccines
Technology Innovations and Investments Bolster Next-generation Prophylactic and Therapeutic RNA Vaccines
RNA therapeutics and vaccines have been around for a long time, but the COVID-19 pandemic enabled their mass-market commercialization. Industry players saw mRNA vaccines developed for COVID-19 as effective for reducing the impact of the SARS-CoV-2 virus in populations. Moderna emerged as the first player to develop and commercialize an mRNA vaccine...
$4,950.00
Special Price $4,207.50 save 15 %
-
16 Nov 2022 | North America | Frost Radar
Frost Radar™: Cell and Gene Therapy Contract Development and Manufacturing Organizations, 2022
A Benchmarking System to Spark Companies to Action-Innovation that Fuels New Deal Flow and Growth Pipelines
As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contract research organizations (CROs) can play a critical role in long-term genetic analysis and monitor safety and efficacy up to 15 years after treat...
$4,950.00
Special Price $4,207.50 save 15 %
-
09 Nov 2022 | Global | Technology Research
Emerging Therapeutics for Rare Neuromuscular Diseases: Pipeline Analysis
Strategic partnering and new product development will enable better biologics for personalized and targeted treatment
Muscle weakness, cramps, and impaired musculoskeletal functions that occur due to rare defects in nerve and muscle cells characterize neuromuscular disorders (NMDs). The disorders are largely classified as motor neuron diseases, hereditary ataxias, peripheral nerve disorders, neuromuscular junction transmission disorders, and myopathies. NMDs prese...
$4,950.00
Special Price $4,207.50 save 15 %
-
05 Sep 2022 | Global | Technology Research
Technology Growth Opportunities for Exosome-Mediated Drug Delivery
Exosomes Are Promising Delivery Carriers for Advanced Therapeutics
Exosome-mediated drug delivery is a promising alternative to conventional drug delivery methods, making rapid strides in the biopharmaceutical industry because of the safety and efficacy advantages exosomes offer as nanocarriers over synthetic nanoparticles. The widely explored concepts of nanomedicine, nucleic acid therapeutics, and cell-free vacc...
$4,950.00
Special Price $4,207.50 save 15 %
-
29 Aug 2022 | Global | Technology Research
Advancements in miRNA: Technology Assessment
Developments in miRNA sequencing and analysis are driving future growth potential in therapeutics and diagnostics
Accelerated research around RNA-based therapeutics and diagnostics, accompanied by technology advancements in sequencing the human genome, has resulted in a better understanding of the role of miRNA in biological pathways, enhancing its potential in both therapeutics and diagnostics. The successful clinical validation of miRNA diagnostic tests has ...
$4,950.00
Special Price $4,207.50 save 15 %
-
23 Aug 2022 | North America | Frost Radar
Frost Radar™: US Liquid Biopsy, 2022
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
The oncology space is maturing rapidly. With the arrival of blood-based assays for cancer screening and the emphasis on early detection, the liquid biopsy segment is seeing increased consolidation and high-impact acquisitions, such as Illumina and GRAIL, Exact Sciences and Thrive Earlier Detection, and Roche Foundation Medicine and Lexent Bio. Comp...
$4,950.00
Special Price $4,207.50 save 15 %
-
17 Aug 2022 | Global | Technology Research
Therapeutic Advances in Amyloidosis
Research Efforts and Technology Developments through Partnerships and Collaborations will Push New Therapeutic Modalities into Treatment Regimens.
Amyloidosis is a rare disease caused by the accumulation and the deposition of proteins such as immunoglobulin light-chain protein in AL amyloidosis and misfolded transthyretin (TTR) protein in ATTR amyloidosis. There are a few other types of amyloidosis as well, which are either a result of a preexisting condition or are not highly prevalent. Vari...
$4,950.00
Special Price $4,207.50 save 15 %
-
17 Jan 2022 | Global | Technology Research
Global Advances in Omics Technologies Enable Future Drug Discovery and Growth Opportunities
Emerging Omics Platforms Drive Precision Drug Discovery
For a long time, drug discovery followed the same path and used conventional analysis methods for proposed targets. Today, changes in technology and the ability to study omics are transforming drug development. Personalized therapy is on the rise and promises to be more effective and efficient in addressing challenges. With growing interest in ...
$4,950.00
Special Price $3,712.50 save 25 %
